2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators

Details for Australian Patent Application No. 2006329040 (hide)

Owner Newron Pharmaceuticals S.p.A.

Inventors Salvati, Patricia; Sabido-David, Cibele; Restivo, Alessandra; Moriggi, Ermanno; Thaler, Florian; Caccia, Carla; Faravelli, Laura; Napoletano, Mauro

Agent Griffith Hack

Pub. Number AU-B-2006329040

PCT Pub. Number WO2007/071311

Priority 05028147.6 22.12.05 EP

Filing date 29 November 2006

Wipo publication date 28 June 2007

Acceptance publication date 28 July 2011

International Classifications

C07D 237/06 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/00 (2006.01) Drugs for disorders of the senses

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/14 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 309/06 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/071311 Priority application(s): WO2007/071311

5 June 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 23 Apr 2008

31 July 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Jul 2008

28 July 2011 Application Accepted

  Published as AU-B-2006329040

8 December 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Jul 2011 2007

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006329042-Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases

2006329039-Heavy-duty roundsling